Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in Persistent or Recurrent Ovarian or Primary Peritoneal Cancer
NCT00113373Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2005
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in ovarian epithelial cancer, primary peritoneal cancer (PPC), sponsored by National Cancer Institute. Started May 2005; status: completed.
02
Drugs
lapatinib
03
Conditions
ovarian epithelial cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00113373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113373.